2021-2023年北京市耐药结核病患者自付医疗费用及影响因素的调查研究

Study of self-paid medical expenses of drug-resistant tuberculosis patients and influencing factors in Beijing, 2021−2023

  • 摘要:
    目的 调查北京市耐药结核病患者的自付医疗费用及其影响因素。
    方法 采用横断面调查设计,选取北京市2021年1月至2023年12月治疗成功的初治利福平耐药结核病患者为研究对象,收集患者的社会人口学信息和医疗费用信息,采用多重线性回归模型分析自付医疗费用的影响因素。
    结果 本次调查共纳入耐药结核病患者158例,年龄中位数为38.5岁,职业以干部职员为主(36例,22.78%),87.34%(138例)的患者患病时参加了各种形式的医疗保险,患者家庭年收入的中位数为100000.0060000.00190000.00)元。 患者例均自付医疗费用为59367.61元,中位数为42280.9523795.7376037.60)元,自付门诊费用占比中位数为80.90%(64.95%,100.00%),自付住院费用占比中位数为28.56%(19.66%,45.60%)。 多因素分析结果显示,年龄、参加医疗保险情况、是否领取免费二线抗结核药品、是否住院、是否使用贝达喹啉、治疗时长是自付医疗费用的影响因素(P<0.05)。
    结论 北京市出台的耐药结核病相关政策确实减轻了患者的医疗费用支出,但部分患者的医疗费用仍然较高。 未来应根据新的疫情防控形势和患者实际医疗需求,出台一些新的政策举措,充分发挥当前各项保障政策的作用,切实减轻患者的经济负担。

     

    Abstract:
    Objective To understand the self-paid medical expenses of drug-resistant tuberculosis (TB) patients in Beijing and indentify influencing factors.
    Methods A cross-sectional survey design was used for this study. The new rifampicin resistant TB patients who were successfully treated in Beijing from January 2021 to December 2023 were included. The patients' sociodemographic information and medical expense information were collected, and a multiple linear regression model was used to analyze the influencing factors of self-paid medical expense.
    Results A total of 158 drug-resistant TB patients were included in this study, and the median of age of the patients was 38.5 years. The patients were mainly staff (36 cases, 22.78%), and 87.34%(138 cases)of the patients had healthcare insurance. The median of annual household income of the patients was 100000.00 (55000.00, 17000.00) yuan. The average self-paid medical expenses of the patients were 59367.61 yuan, the median was 42280.95 (23795.73, 76037.60) yuan. The median proportion of self-paid outpatient expenses was 80.90% (64.95%, 100.00%), and the median proportion of self-paid hospitalization expenses was 28.56% (19.66%, 45.60%). The results of multivariate analysis showed that age, medical insurance, free second-line anti-TB drug treatment, hospitalization, bedaquiline use and the duration of treatment were influencing factors of self-paid medical expenses of drug resistant TB patients (P<0.05).
    Conclusion The implementation of drug-resistant TB treatment policies of Beijing has benefited the reduction of the medical expenses of the patients, but the medical expenses of some drug resistant TB patients are still high. New policies should be developed and new measures should be taken according to the current incidence or prevalence of TB and the actual medical needs of patients to further reduce the economic burden of drug resistant TB patients.

     

/

返回文章
返回